MedTrace Logo

Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft

NCT02855827 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2024-07-12

No results posted yet for this study

Summary

Ovarian cryopreservation is one of the available option for preserving fertility prior to potentially sterilizing treatments. In the absence of other techniques such as in vitro folliculogenesis or injection of isolated ovarian follicles, this tissue can only be re-used by autograft. In France, the first live birth after orthotopic ovarian transplantation, was obtained by Roux et al. in 2009.

This clinical trial aims to build a cohort of patients likely to use their ovarian tissue cryopreserved by autograft.

Conditions

  • Ovarian Function Insufficiency

Sponsors & Collaborators

  • CHU de Reims

    collaborator OTHER

  • University Hospital, Marseille

    collaborator OTHER

  • University Hospital, Lille

    collaborator OTHER

  • Central Hospital, Nancy, France

    collaborator OTHER

  • University Hospital, Grenoble

    collaborator OTHER

  • CMCO SIHCUS, Schiltingheim

    collaborator OTHER

  • University Hospital, Bordeaux

    collaborator OTHER

  • Nantes University Hospital

    collaborator OTHER

  • University Hospital, Limoges

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Eligibility

Min Age
11 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02855827 on ClinicalTrials.gov